Apollomics Inc. (APLM) stock

APLMNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as APLMW

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 24, 2026Score 0/30

$17.68+0.38 (+2.20%)

Close on Nov 13, 2026Market cap $38.83MP/E –Yield –

Apollomics EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Apollomics's EV/EBITDA was 2.3× on Dec 29, 2023.

Period	Period end	Value	Change (pts)
2023	Dec 29, 2023	2.3×	–

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is APLM.

Advertisement
300 × 250

See a number that looks wrong?